1. Metformin: current clinical applications in nondiabetic patients with cancer
   Kailin Chen et al, 2020, Aging CrossRef
2. Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials
   Michael Troncone et al, 2017, Oncotarget CrossRef
3. Ianus Bifrons: The Two Faces of Metformin
   Umberto Goglia et al, 2024, Cancers CrossRef
4. Dietary Folate Deficiency Promotes Lactate Metabolic Disorders to Sensitize Lung Cancer Metastasis through MTOR-Signaling-Mediated Druggable Oncotargets
   Wan-Jing Chen et al, 2023, Nutrients CrossRef
5. Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance)
   Preet Paul Singh et al, 2016, The Oncologist CrossRef
6. Inhibition effects of Yuxiao San combined with cisplatin on transplanted tumor growths via upregulation of nm‑23 and downregulation of K‑ras in Lewis lung cancer mice
   Mo Tang et al, 2018, Oncology Letters CrossRef
7. Metformin: A Novel but Controversial Drug in Cancer Prevention and Treatment
   Xinbing Sui et al, 2015, Molecular Pharmaceutics CrossRef
8. Metformin Addition to Chemotherapy in Stage IV Non-Small Cell Lung Cancer: an Open Label Randomized Controlled Study
   Rana Sayed et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef
9. Antineoplastic potential of metformin in colorectal cancer
   Francisco José Fernández-Fernández, 2017, European Journal of Internal Medicine CrossRef
10. A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition
    Pedro Barrios-Bernal et al, 2023, International Journal of Molecular Sciences CrossRef
11. Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with Auger electron emitting, 111In or β-particle emitting, 177Lu
    Sadaf Aghevlian et al, 2020, EJNMMI Radiopharmacy and Chemistry CrossRef
12. Assembling defined DNA nanostructures with anticancer drugs: a metformin/DNA complex nanoplatform with a synergistic antitumor effect for KRAS-mutated lung cancer therapy
    Hang Qian et al, 2022, NPG Asia Materials CrossRef
13. Heparanase Cooperates with Ras to Drive Breast and Skin Tumorigenesis
    Ilanit Boyango et al, 2014, Cancer Research CrossRef
14. Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery
    Mihaela Aldea et al, 2014, Tumor Biology CrossRef
15. Metformin in Lung Cancer: Review of in Vitro and in Vivo Animal Studies
    Michael Yousef et al, 2017, Cancers CrossRef
16. Effects of metformin on tumor hypoxia and radiotherapy efficacy: a [18F]HX4 PET imaging study in colorectal cancer xenografts
    Sven De Bruycker et al, 2019, EJNMMI Research CrossRef
17. The antitumor effect of metformin with and without carboplatin on primary endometrioid endometrial carcinoma in vivo
    Stefanie Schrauwen et al, 2015, Gynecologic Oncology CrossRef
18. Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention
    Claudio Pulito et al, 2013, Metabolites CrossRef
19. Is metformin a geroprotector? A peek into the current clinical and experimental data
    Agnieszka Zajda et al, 2020, Mechanisms of Ageing and Development CrossRef
20. Advances in metformin‑based metabolic therapy for non‑small cell lung cancer (Review)
    Na Chen et al, 2022, Oncology Reports CrossRef